Ted Wojno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ted Wojno has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Brent Hayek
Division of Oculoplastics, Orbital and Cosmetic Surgery, Emory University, Atlanta, Georgia, USA
1 shared publication Cecilia S. Jung
Department of Ophthalmology, Emory University, Atlanta, GA, USA
1 shared publication- Ian Crocker
Department of Radiation Oncology, Emory University, 1365 Clifton Rd. NE, Atlanta, GA 30322, USA
1 shared publication Joseph D. Walrath
Paces Plastic Surgery, Atlanta
1 shared publication- Lang Liebman
Radiation Oncology Associates, Richmond, Georgia, USA
1 shared publication Patricia A. Hudgins
Department of Radiology and Imaging Sciences, Emory, Atlanta, GA, USA
1 shared publication
Latest Publications
- 13 June 2022
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 42 (11) , 1250-1251
Commentary on: Do Prostaglandin Analogue Lash Lengtheners Cause Eyelid Fat and Volume Loss?
Ted Wojno, MD; Commentary on: Do Prostaglandin Analogue Lash Lengtheners Cause Eyelid Fat and Volume Loss?, Aesthetic Surgery Journal, , sjac154, https://doi.or
- 13 June 2022
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 42 (11) , 1250-1251
Commentary on: Do Prostaglandin Analogue Lash Lengtheners Cause Eyelid Fat and Volume Loss?
Ted Wojno, MD; Commentary on: Do Prostaglandin Analogue Lash Lengtheners Cause Eyelid Fat and Volume Loss?, Aesthetic Surgery Journal, , sjac154, https://doi.or
- 2 April 2021
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 41 (10) , 1130-1131
Commentary on: A Comprehensive Approach to Asian Upper Eyelid Ptosis Correction: The Levator Musculo-Aponeurotic Junction Formula
General Sherman stated that “war is hell.” This was famously paraphrased by Richard K. Dortzbach, MD, who stated that “ptosis is hell.” This basically sums up the experience of many surgeons who routinely perform ptosis repair by itself or in conjunction with aesthetic upper eyelid blepharoplasty.
- 2 April 2021
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 41 (10) , 1130-1131
Commentary on: A Comprehensive Approach to Asian Upper Eyelid Ptosis Correction: The Levator Musculo-Aponeurotic Junction Formula
General Sherman stated that “war is hell.” This was famously paraphrased by Richard K. Dortzbach, MD, who stated that “ptosis is hell.” This basically sums up the experience of many surgeons who routinely perform ptosis repair by itself or in conjunction with aesthetic upper eyelid blepharoplasty.
- 30 May 2019
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 39 (12) , 1295-1296
Commentary on: “Dynamic Canthopexy” Drill Hole Canthal Repositioning
The Bermuda Triangle, also known as The Devil’s Triangle, is an ill-defined area of sea bounded by Bermuda, Florida, and Puerto Rico. It has inspired dread and fascination and been the subject of a few scholarly and even more not-so-scholarly books, articles, and movies. In general, critical thinking has debunked the notion of danger in this area. Unfortunately, the same cannot be said for that triangular area of soft tissue at the outer conjunction of the upper and lower eyelids: the lateral canthus. It continues to inspire fear in those who venture there and can create disaster for the surgical mariner who is not properly equipped with knowledge of how to chart a course through...
- 30 May 2019
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 39 (12) , 1295-1296
Commentary on: “Dynamic Canthopexy” Drill Hole Canthal Repositioning
The Bermuda Triangle, also known as The Devil’s Triangle, is an ill-defined area of sea bounded by Bermuda, Florida, and Puerto Rico. It has inspired dread and fascination and been the subject of a few scholarly and even more not-so-scholarly books, articles, and movies. In general, critical thinking has debunked the notion of danger in this area. Unfortunately, the same cannot be said for that triangular area of soft tissue at the outer conjunction of the upper and lower eyelids: the lateral canthus. It continues to inspire fear in those who venture there and can create disaster for the surgical mariner who is not properly equipped with knowledge of how to chart a course through...
- Open Access
- 22 September 2015
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 36 (2) , NP96-NP97
Pearls and Pitfalls in Cosmetic Oculoplastic Surgery
Overall, the strengths and weaknesses balance out and this text will find its place in many a physician's armamentarium of references. It should be of use to th
- 22 September 2015
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 36 (2) , NP96-NP97
Open AccessPearls and Pitfalls in Cosmetic Oculoplastic Surgery
Overall, the strengths and weaknesses balance out and this text will find its place in many a physician's armamentarium of references. It should be of use to th
- Open Access
- 19 June 2012
- Published by Springer Nature in Radiation Oncology
- Vol. 7 (1) , 95
Clinical outcomes of radiotherapy as initial local therapy for Graves’ ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery
The optimal initial local treatment for patients with Graves’ ophthalmopathy (GO) is not fully characterized. The purpose of this retrospective study is to describe the clinical outcomes of RT as initial local therapy for GO and define predictors of the need for post-RT salvage bony decompressive surgery.
- 19 June 2012
- Published by Springer Nature in Radiation Oncology
- Vol. 7 (1) , 95
Open AccessClinical outcomes of radiotherapy as initial local therapy for Graves’ ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery
The optimal initial local treatment for patients with Graves’ ophthalmopathy (GO) is not fully characterized. The purpose of this retrospective study is to describe the clinical outcomes of RT as initial local therapy for GO and define predictors of the need for post-RT salvage bony decompressive surgery.
- 25 May 2012
- Published by Taylor & Francis in Orbit
- Vol. 31 (5) , 341-343
Diffuse Symmetric Meningioma En Plaque Mimicking Metabolic Disease of Bone
A 50-year-old African American woman with right proptosis and decreased vision demonstrated symmetric, bilateral thickening of the sphenoid wings, calvarium, and skull base on computed tomography. Histopathologic evaluation of the hyperostotic lesion was consistent with meningotheliomatous meningioma. The patient underwent uncomplicated right frontal orbital craniectomy with postoperative radiation. The presentation of en plaque meningioma, when diffuse and symmetric, can mimic a metabolic disease of bone.
- 25 May 2012
- Published by Taylor & Francis in Orbit
- Vol. 31 (5) , 341-343
Diffuse Symmetric Meningioma En Plaque Mimicking Metabolic Disease of Bone
A 50-year-old African American woman with right proptosis and decreased vision demonstrated symmetric, bilateral thickening of the sphenoid wings, calvarium, and skull base on computed tomography. Histopathologic evaluation of the hyperostotic lesion was consistent with meningotheliomatous meningioma. The patient underwent uncomplicated right frontal orbital craniectomy with postoperative radiation. The presentation of en plaque meningioma, when diffuse and symmetric, can mimic a metabolic disease of bone.
- 1 March 2011
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 27 (2) , 119-121
Results of Lacrimal Gland Botulinum Toxin Injection for Epiphora in Lacrimal Obstruction and Gustatory Tearing
Purpose: To describe the author's experience with the use of botulinum toxin (Botox, Allergan Inc., Irvine, CA, U.S.A.) injection in the palpebral lobe of the lacrimal gland for symptomatic epiphora due to lacrimal obstruction or gustatory tearing. Methods: This is a retrospective review of 46 patients treated by the author with botulinum toxin injection in the palpebral lobe of the lacrimal gland for symptomatic epiphora due to lacrimal obstruction or gustatory tearing from 2001 through 2008. All patients were injected with 2.5 units of botulinum toxin, and the patients' subjective responses were assessed 1 to 2 weeks later. If there was insufficient response, they were reinjected with an additional 2.5 units of botulinum toxin and re-evaluated in 1 to 2 weeks. The response to the treatment and complications were evaluated. Results: Overall, 74% of patients treated felt that tearing was mostly or completely improved. The only complication was temporary ptosis in 11% of the patients. Conclusion: Botulinum toxin injection in the palpebral lobe of the lacrimal gland can be used effectively and safely for symptomatic epiphora due to lacrimal obstruction and gustatory tearing. Although the beneficial results are temporary, the patient satisfaction in selected patients is high.
- 1 March 2011
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 27 (2) , 119-121
Results of Lacrimal Gland Botulinum Toxin Injection for Epiphora in Lacrimal Obstruction and Gustatory Tearing
Purpose: To describe the author's experience with the use of botulinum toxin (Botox, Allergan Inc., Irvine, CA, U.S.A.) injection in the palpebral lobe of the lacrimal gland for symptomatic epiphora due to lacrimal obstruction or gustatory tearing. Methods: This is a retrospective review of 46 patients treated by the author with botulinum toxin injection in the palpebral lobe of the lacrimal gland for symptomatic epiphora due to lacrimal obstruction or gustatory tearing from 2001 through 2008. All patients were injected with 2.5 units of botulinum toxin, and the patients' subjective responses were assessed 1 to 2 weeks later. If there was insufficient response, they were reinjected with an additional 2.5 units of botulinum toxin and re-evaluated in 1 to 2 weeks. The response to the treatment and complications were evaluated. Results: Overall, 74% of patients treated felt that tearing was mostly or completely improved. The only complication was temporary ptosis in 11% of the patients. Conclusion: Botulinum toxin injection in the palpebral lobe of the lacrimal gland can be used effectively and safely for symptomatic epiphora due to lacrimal obstruction and gustatory tearing. Although the beneficial results are temporary, the patient satisfaction in selected patients is high.
- 1 September 2010
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 26 (5) , 327-329
Experience With a Medpor-Coated Tear Drain
To determine the results with a Medpor-coated tear drain in conjunctivodacryocystorhinostomy. This was a retrospective case review of all patients who underwent conjunctivodacryocystorhinostomy with a Medpor-coated tear drain by the author. The success rate and complications were determined. Sixteen patients had placement of 17 Medpor-coated tear drains. Twelve of the 16 patients (75%) were doing well at the last follow-up visit with a well-positioned, functioning tear drain tube. Four patients (25%) required tube removal for assorted reasons, 2 of whom had an early prototype of the tube. The Medpor-coated tear drain is an effective device for bypass of the lacrimal drainage system in conjunctivodacryocystorhinostomy. The current design of the tube should minimize complications while ensuring stable placement and retention.
- 1 September 2010
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 26 (5) , 327-329
Experience With a Medpor-Coated Tear Drain
To determine the results with a Medpor-coated tear drain in conjunctivodacryocystorhinostomy. This was a retrospective case review of all patients who underwent conjunctivodacryocystorhinostomy with a Medpor-coated tear drain by the author. The success rate and complications were determined. Sixteen patients had placement of 17 Medpor-coated tear drains. Twelve of the 16 patients (75%) were doing well at the last follow-up visit with a well-positioned, functioning tear drain tube. Four patients (25%) required tube removal for assorted reasons, 2 of whom had an early prototype of the tube. The Medpor-coated tear drain is an effective device for bypass of the lacrimal drainage system in conjunctivodacryocystorhinostomy. The current design of the tube should minimize complications while ensuring stable placement and retention.